BTMPS

BTMPS is a nicotine receptor (nAChR) antagonist that can lessen the negative effects of morphine on rats[1].

Product Specifications

CAS Number

[52829-07-9]

UNSPSC

12352005

Hazard Statement

H318, H400, H411

Target

NAChR

Related Pathways

Membrane Transporter/Ion Channel; Neuronal Signaling

Field of Research

Neurological Disease

Purity

98.0

Solubility

DMSO : 10 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

O=C(OC1CC(C)(C)NC(C)(C)C1)CCCCCCCCC(OC2CC(C)(C)NC(C)(C)C2)=O

Molecular Formula

C28H52N2O4

Molecular Weight

480.73

Precautions

H318, H400, H411

References & Citations

[1]Brandon J Hall, et al. The use-dependent, nicotinic antagonist BTMPS reduces the adverse consequences of morphine self-administration in rats in an abstinence model of drug seeking. Neuropharmacology. 2011 Sep;61 (4) :798-806.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, protect from light)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

MBS8124394-01 0.1 mL

PFDN1 Antibody, Rabbit PAb, Antigen Affinity Purified

Ask

View Details

MBS8124394-02 5x 0.1 mL

PFDN1 Antibody, Rabbit PAb, Antigen Affinity Purified

Ask

View Details

TA502789AM 100 µL

LMCD1 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI2F12]

Ask

View Details

LC410056 20 µg

TUBB6 (NM_032525) Human Over-expression Lysate

Ask

View Details

ICH5180-1g 1 g

Bamlanivimab Biosimilar - Research Grade

Ask

View Details